199 related articles for article (PubMed ID: 3157318)
1. Nifedipine in the treatment of Raynaud's phenomenon. Evidence for inhibition of platelet activation.
Malamet R; Wise RA; Ettinger WH; Wigley FM
Am J Med; 1985 Apr; 78(4):602-8. PubMed ID: 3157318
[TBL] [Abstract][Full Text] [Related]
2. Nicardipine in the treatment of Raynaud's phenomenon. Dissociation of platelet activation from vasospasm.
Wigley FM; Wise RA; Malamet R; Scott TE
Arthritis Rheum; 1987 Mar; 30(3):281-6. PubMed ID: 2952125
[TBL] [Abstract][Full Text] [Related]
3. Controlled double-blind trial of dazoxiben and nifedipine in the treatment of Raynaud's phenomenon.
Ettinger WH; Wise RA; Schaffhauser D; Wigley FM
Am J Med; 1984 Sep; 77(3):451-6. PubMed ID: 6540986
[TBL] [Abstract][Full Text] [Related]
4. Dazoxiben, a thromboxane synthetase inhibitor, in Raynaud's phenomenon.
Luderer JR; Nicholas GG; Neumyer MM; Riley DL; Vary JE; Garcia G; Schneck DW
Clin Pharmacol Ther; 1984 Jul; 36(1):105-15. PubMed ID: 6428793
[TBL] [Abstract][Full Text] [Related]
5. Calcium channel blockers for primary Raynaud's phenomenon.
Ennis H; Hughes M; Anderson ME; Wilkinson J; Herrick AL
Cochrane Database Syst Rev; 2016 Feb; 2(2):CD002069. PubMed ID: 26914257
[TBL] [Abstract][Full Text] [Related]
6. Plasma beta-thromboglobulin in the differential diagnosis of Raynaud's phenomenon.
Seibold JR; Harris JN
J Rheumatol; 1985 Feb; 12(1):99-103. PubMed ID: 2580093
[TBL] [Abstract][Full Text] [Related]
7. Assessment of platelet function in patients with Raynaud's syndrome.
Hutton RA; Mikhailidis DP; Bernstein RM; Jeremy JY; Hughes GR; Dandona P
J Clin Pathol; 1984 Feb; 37(2):182-7. PubMed ID: 6229551
[TBL] [Abstract][Full Text] [Related]
8. Calcium channel blockers for primary Raynaud's phenomenon.
Ennis H; Anderson ME; Wilkinson J; Herrick AL
Cochrane Database Syst Rev; 2014 Jan; (1):CD002069. PubMed ID: 24482037
[TBL] [Abstract][Full Text] [Related]
9. A thromboxane synthetase inhibitor in Raynaud's phenomenon.
Jones EW; Hawkey CJ
Prostaglandins Leukot Med; 1983 Sep; 12(1):67-71. PubMed ID: 6356154
[TBL] [Abstract][Full Text] [Related]
10. Effect of the calcium channel blocker nifedipine on Raynaud's phenomenon. A controlled double blind trial.
Sauza J; Kraus A; González-Amaro R; Alarcón-Segovia D
J Rheumatol; 1984 Jun; 11(3):362-4. PubMed ID: 6376801
[TBL] [Abstract][Full Text] [Related]
11. Effect of dazoxiben, a thromboxane synthetase inhibitor on skin-blood flow following cold challenge in patients with Raynaud's phenomenon.
Tindall H; Tooke JE; Menys VC; Martin MF; Davies JA
Eur J Clin Invest; 1985 Feb; 15(1):20-3. PubMed ID: 3921380
[TBL] [Abstract][Full Text] [Related]
12. [Platelet function study in primary Raynaud's phenomenon and Raynaud's phenomenon associated with scleroderma].
Cuenca R; Fernández-Cortijo J; Lima J; Fonollosa V; Simeón CP; Pico M; Soriano B; Vilardell M
Med Clin (Barc); 1990 Dec; 95(20):761-3. PubMed ID: 2151867
[TBL] [Abstract][Full Text] [Related]
13. Effect of thromboxane synthetase inhibition in Raynaud's phenomenon.
Coffman JD; Rasmussen HM
Clin Pharmacol Ther; 1984 Sep; 36(3):369-73. PubMed ID: 6467796
[TBL] [Abstract][Full Text] [Related]
14. Comparison of intravenous infusions of iloprost and oral nifedipine in treatment of Raynaud's phenomenon in patients with systemic sclerosis: a double blind randomised study.
Rademaker M; Cooke ED; Almond NE; Beacham JA; Smith RE; Mant TG; Kirby JD
BMJ; 1989 Mar; 298(6673):561-4. PubMed ID: 2467711
[TBL] [Abstract][Full Text] [Related]
15. Treatment of Raynaud's phenomenon with calcium channel blockers.
Smith CR; Rodeheffer RJ
Am J Med; 1985 Feb; 78(2B):39-42. PubMed ID: 3976694
[TBL] [Abstract][Full Text] [Related]
16. Clinical and laboratory effects of nifedipine in Raynaud's phenomenon.
Hawkins SJ; Black CM; Hall ND; McGregor A; Ring EF; Maddison PJ
Rheumatol Int; 1986; 6(2):85-8. PubMed ID: 3764307
[TBL] [Abstract][Full Text] [Related]
17. Acute effects of nifedipine on digital blood flow in human subjects with Raynaud's phenomenon: a double blind placebo controlled trial.
Wise RA; Malamet R; Wigley FM
J Rheumatol; 1987 Apr; 14(2):278-83. PubMed ID: 3298649
[TBL] [Abstract][Full Text] [Related]
18. Controlled double-blind trial of the clinical effect of nifedipine in the treatment of idiopathic Raynaud's phenomenon.
Gjørup T; Kelbaek H; Hartling OJ; Nielsen SL
Am Heart J; 1986 Apr; 111(4):742-5. PubMed ID: 3513504
[TBL] [Abstract][Full Text] [Related]
19. Controlled double blind trial of nisoldipine in the treatment of idiopathic Raynaud's phenomenon.
Gjørup T; Hartling OJ; Kelbaek H; Nielsen SL
Eur J Clin Pharmacol; 1986; 31(4):387-9. PubMed ID: 3816916
[TBL] [Abstract][Full Text] [Related]
20. A randomized double blind cross-over trial of nifedipine in the treatment of primary Raynaud's phenomenon.
Corbin DO; Wood DA; Macintyre CC; Housley E
Eur Heart J; 1986 Feb; 7(2):165-70. PubMed ID: 3516704
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
